We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.15B
AUM Growth
-$3.94B
Cap. Flow
-$4.44B
Cap. Flow %
-106.94%
Top 10 Hldgs %
33.3%
Holding
6,378
New
470
Increased
1,548
Reduced
3,513
Closed
532

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$61.6M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$32.2M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$21.8M
4
USO icon
United States Oil Fund
USO
+$12.8M
5
XLB icon
State Street Materials Select Sector SPDR ETF
XLB
+$11.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$263M
2
AAPL icon
Apple
AAPL
+$226M
3
AMZN icon
Amazon
AMZN
+$127M
4
NVDA icon
NVIDIA
NVDA
+$115M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$80.9M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Consumer Discretionary 9.21%
3 Communication Services 8.49%
4 Financials 7.96%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAIN icon
3026
Main Street Capital
MAIN
$5.49B
$19.4K ﹤0.01%
409
+165
+68% +$7.46K
MATV icon
3027
Mativ Holdings
MATV
$674M
$19.4K ﹤0.01%
1,032
-21,694
-95% -$324K
SEB icon
3028
Seaboard Corp
SEB
$4.14B
$19.3K ﹤0.01%
6
-24
-80% -$82.6K
CNOB icon
3029
Center Bancorp
CNOB
$1.79B
$19.3K ﹤0.01%
989
-9,484
-91% -$199K
SCHO icon
3030
Schwab Short-Term US Treasury ETF
SCHO
$13B
$19.3K ﹤0.01%
800
+532
+199% +$12.8K
TILE icon
3031
Interface
TILE
$2.19B
$19.3K ﹤0.01%
1,146
-30,136
-96% -$417K
LABP
3032
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$19.2K ﹤0.01%
+896
New +$5.94K
EPC icon
3033
Edgewell Personal Care
EPC
$1.31B
$19.2K ﹤0.01%
498
-13,866
-97% -$523K
CGGR icon
3034
Capital Group Growth ETF
CGGR
$25.1B
$19.2K ﹤0.01%
601
-6,015
-91% -$181K
EUM icon
3035
ProShares Trust Short MSCI Emerging Markets
EUM
$9.3M
$19.2K ﹤0.01%
688
-54
-7% -$1.56K
VRDN icon
3036
Viridian Therapeutics
VRDN
$2.5B
$19.2K ﹤0.01%
1,096
-1,235
-53% -$23.9K
GRTS
3037
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$19.2K ﹤0.01%
7,455
-305
-4% -$745
SUIG
3038
Sui Group Holdings
SUIG
$62.4M
$19.1K ﹤0.01%
7,226
+4,241
+142% +$11.1K
BOTZ icon
3039
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.58B
$19.1K ﹤0.01%
601
+257
+75% +$7.74K
USCB icon
3040
USCB Financial Holdings
USCB
$417M
$19.1K ﹤0.01%
1,677
+909
+118% +$10.5K
CPRX
3041
DELISTED
Catalyst Pharmaceutical
CPRX
$19.1K ﹤0.01%
1,199
-4,985
-81% -$75.1K
YSG
3042
Yatsen Holding
YSG
$317M
$19.1K ﹤0.01%
9,055
+8,561
+1,733% +$25.4K
NRIX icon
3043
Nurix Therapeutics
NRIX
$2.8B
$19.1K ﹤0.01%
1,298
-22,307
-95% -$240K
WDH
3044
Waterdrop
WDH
$359M
$19.1K ﹤0.01%
14,768
+5,432
+58% +$6.04K
BELFA icon
3045
Bel Fuse Inc Class A
BELFA
$3.47B
$19K ﹤0.01%
269
+72
+37% +$4.84K
PCT icon
3046
PureCycle Technologies
PCT
$1.39B
$19K ﹤0.01%
3,062
-20,492
-87% -$95.4K
KYTX icon
3047
Kyverna Therapeutics
KYTX
$506M
$19K ﹤0.01%
+766
New +$21.4K
BIOX icon
3048
Bioceres Crop Solutions
BIOX
$28.1M
$19K ﹤0.01%
1,502
+479
+47% +$6.31K
MGIC
3049
DELISTED
Magic Software Enterprises
MGIC
$19K ﹤0.01%
1,657
+1,361
+460% +$14.7K
NVNO
3050
enVVeno Medical
NVNO
$7.5M
$19K ﹤0.01%
100
+19
+23% +$3.41K
120 121
122
123 124

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2024 Portfolio in Review

As of Q1 2024, Tower Research Capital (TRC) held 6,378 positions worth $4.15B, down 49% from $8.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.44B in Q1 2024, closing 532 positions and reducing 3,513 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares S&P Small-Cap 600 Growth ETF worth $3.77M.

  • Tower Research Capital (TRC)'s largest Q1 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 28,851 shares worth $3.77M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2024, an estimated $61.6M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2024 reduction was Microsoft, cutting an estimated $263M.
  • Tower Research Capital (TRC) fully exited State Street Financial Select Sector SPDR ETF in Q1 2024, selling an estimated $49.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 33% of its $4.15B portfolio in Q1 2024.
  • Tower Research Capital (TRC) opened 470 new positions and closed 532 in Q1 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 49% quarter-over-quarter to $4.15B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.